Cargando…
CpG oligodeoxyribonucleotide 7909 enhances radiosensitivity via downregulating Oct-4 expression in radioresistant lung cancer cells
Radiotherapy is a powerful cure for local advanced non-small cell lung cancer. However, radioresistance and tumor relapse still occur in a high proportion of patients. Octamer-4 (Oct-4), a transcription factor of the POU family, plays a key role in maintaining chemoradioresistant properties and regu...
Autores principales: | Xing, Na, Qiao, Tiankui, Zhuang, Xibing, Yuan, Sujuan, Zhang, Qi, Xu, Guoxiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472028/ https://www.ncbi.nlm.nih.gov/pubmed/26109868 http://dx.doi.org/10.2147/OTT.S84467 |
Ejemplares similares
-
Dose-effect relationship of CpG oligodeoxyribonucleotide 1826 in murine Lewis lung cancer treated with irradiation
por: Zhuang, Xibing, et al.
Publicado: (2013) -
Radiosensitization by CpG ODN7909 in an epidermoid laryngeal
carcinoma Hep-2 cell line
por: Wang, Shu, et al.
Publicado: (2017) -
Impact of CHK2-small interfering RNA on CpG ODN7909-enhanced radiosensitivity in lung cancer A549 cells
por: Chen, Wei, et al.
Publicado: (2012) -
Effects of CpG oligodeoxynucleotide 1826 on acute radiation-induced lung injury in mice
por: Li, Xuan, et al.
Publicado: (2016) -
High-dose irradiation in combination with toll-like receptor 9 agonist CpG oligodeoxynucleotide 7909 downregulates PD-L1 expression via the NF-κB signaling pathway in non-small cell lung cancer cells
por: Chen, Xue, et al.
Publicado: (2016)